Skip to main content
. 2018 Jun 23;11(3):62. doi: 10.3390/ph11030062

Figure 2.

Figure 2

Three-dimensional (3-D) space-filling models of one of the author’s developed aptamers using YASARA [21] to analyze the accessibility of potentially inflammatory CpG sequences and alterations to the 3-D structure of the putative binding site (left) once it is excised from the complete aptamer (right). The figure also summarizes a list of approaches to evaluating and rectifying potential CpG toxicity problems. PEG = polyethylene glycol.